Thursday, November 03, 2022
Solesis announced today that it has acquired Polyzen, LLC, a leading developer and manufacturer of polymer-based film and coating technologies for the medical device and biopharmaceutical industries. The addition of Polyzen will expand Solesis’ design and manufacturing capabilities in advanced biomaterials and broaden the service offering it delivers to its customers.
“We are thrilled about what this new partnership will mean for our customers going forward,” said Karen West, CEO of Solesis. “Polyzen enhances Solesis’ breadth of polymer-based technologies, know-how, and capabilities, all of which will enable us to continue to provide innovative solutions to our customers.”
“We are excited to combine our decades of polymer science experience in film and coating technologies with Solesis’ market leadership in advanced biomaterials,” commented Nikin and Rubin Shah, Co-CEOs of Polyzen. “As part of Solesis, we look forward to innovating and developing polymer technology solutions to support our global medical device and bioprocessing customers.”
Based in Apex, NC, Polyzen will operate as a subsidiary of Solesis.
Cleary Gottlieb acted as legal counsel to Solesis. Polyzen was advised by Piper Sandler & Co. and Bagchi Law.
